Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
Thrombosis Research
|
October 11, 2021
Resistance to activated protein C and impaired TFPI activity in women with previous hormone-induced venous thromboembolism
S N Tchaikovski, M C L G D Thomassen, E Stickeler, et al.
Thrombosis and Haemostasis
|
May 12, 2005
Effect of oral contraceptives on the anticoagulant activity of protein S in plasma
Rory R Koenen, M Christella, L G D Thomassen, et al.
Thrombosis Research
|
September 28, 2014
Changes in haemostatic parameters during the menstrual cycle and subsequent use of drospirenone-containing oral contraceptives
S N Tchaikovski, M C L G D Thomassen, S D Costa, et al.
Chemical Research in Toxicology
|
May 1, 1992
The calcium-binding protein calreticulin is covalently modified in rat liver by a reactive metabolite of the inhalation anesthetic halothane
L E Butler, D Thomassen, J L Martin, et al.
Hepatology (Baltimore, Md.)
|
October 1, 1993
Halothane hepatitis patients have serum antibodies that react with protein disulfide isomerase
J L Martin, J G Kenna, B M Martin, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
December 23, 2004
Effect of raloxifene on activated protein C (APC) resistance in postmenopausal women and on APC resistance and homocysteine levels in elderly men: two randomized placebo-controlled studies
Erik J J Duschek, Simone J Neele, M Christella L G D Thomassen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 18, 2017
New functional assays to selectively quantify the activated protein C- and tissue factor pathway inhibitor-cofactor activities of protein S in plasma
N A Alshaikh, J Rosing, M C L G D Thomassen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 28, 2007
Differential effects of high prothrombin levels on thrombin generation depending on the cause of the hyperprothrombinemia
E Castoldi, P Simioni, D Tormene, et al.
Thrombosis and Haemostasis
|
October 8, 2011
Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsia
S N Tchaikovski, M C L G D Thomassen, S-D Costa, et al.
Chemical Research in Toxicology
|
September 1, 1993
Serum antibodies from halothane hepatitis patients react with the rat endoplasmic reticulum protein ERp72
N R Pumford, B M Martin, D Thomassen, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
Thrombosis Research
|
October 11, 2021
Resistance to activated protein C and impaired TFPI activity in women with previous hormone-induced venous thromboembolism
S N Tchaikovski, M C L G D Thomassen, E Stickeler, et al.
Thrombosis and Haemostasis
|
May 12, 2005
Effect of oral contraceptives on the anticoagulant activity of protein S in plasma
Rory R Koenen, M Christella, L G D Thomassen, et al.
Thrombosis Research
|
September 28, 2014
Changes in haemostatic parameters during the menstrual cycle and subsequent use of drospirenone-containing oral contraceptives
S N Tchaikovski, M C L G D Thomassen, S D Costa, et al.
Chemical Research in Toxicology
|
May 1, 1992
The calcium-binding protein calreticulin is covalently modified in rat liver by a reactive metabolite of the inhalation anesthetic halothane
L E Butler, D Thomassen, J L Martin, et al.
Hepatology (Baltimore, Md.)
|
October 1, 1993
Halothane hepatitis patients have serum antibodies that react with protein disulfide isomerase
J L Martin, J G Kenna, B M Martin, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
December 23, 2004
Effect of raloxifene on activated protein C (APC) resistance in postmenopausal women and on APC resistance and homocysteine levels in elderly men: two randomized placebo-controlled studies
Erik J J Duschek, Simone J Neele, M Christella L G D Thomassen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 18, 2017
New functional assays to selectively quantify the activated protein C- and tissue factor pathway inhibitor-cofactor activities of protein S in plasma
N A Alshaikh, J Rosing, M C L G D Thomassen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 28, 2007
Differential effects of high prothrombin levels on thrombin generation depending on the cause of the hyperprothrombinemia
E Castoldi, P Simioni, D Tormene, et al.
Thrombosis and Haemostasis
|
October 8, 2011
Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsia
S N Tchaikovski, M C L G D Thomassen, S-D Costa, et al.
Chemical Research in Toxicology
|
September 1, 1993
Serum antibodies from halothane hepatitis patients react with the rat endoplasmic reticulum protein ERp72
N R Pumford, B M Martin, D Thomassen, et al.
Page
of 5